CHIRON VISION GAINS FOOTHOLD IN EUROPEAN EYE SURGERY MARKET
This article was originally published in The Gray Sheet
Executive Summary
CHIRON VISION GAINS FOOTHOLD IN EUROPEAN EYE SURGERY MARKET through the acquisition of Laboratoires Domilcns S.A., a Lyons, France-based manufacturer and distributor of intraocular lenses and other ophthalmic surgical products. "Together with our Chiron Adatomed subsidiary, Domilens gives Chiron Vision the leading position in Germany and France, two important European ophthalmic surgery markets," Chiron Vision Chairman and CEO William Link, PhD said in a May 10 release announcing the purchase. "Its distributor network will allow the introduction of Chiron Vision products into new markets."
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.